Rob Borbidge

Rob Borbidge (also known as Robert Borbidge) is currently on the Senate for Griffith University (Australia) and was the Premier for Queensland for the National Party from 1996-1998.

In November 2001, Rob Borbidge was appointed as the Chairperson of the Griffith University Centre for Biomolecular Science and Drug Discovery fundraising campaign (now the Institute for Glycomics). [1]

The Director of the Institute for Glycomics is Professor Mark von Itzstein, an Australia Prize winner for his efforts in the development of the Anti-Influenza Drug Zanamivir sold under the name Relenza.

Organisational responsibilities

• Chairman and Independent Non Executive Director for CEC Group, one of Queensland's leading construction and development companies.
• Director of Strategic Communications Australia Pty Ltd, a Queensland based corporate relations company with offices in Brisbane and Jakarta.
• Chairman of Rotec Pty Ltd, a Brisbane based engineering firm that is developing emission reduction technology for diesel engines.
• Chairman of Asset Loan Company, a Gold Coast based ASX listed financial services company.
• Chairman of the Executive Task Force for the Institute of Glycomics at Griffith University.
• Senate member for Griffith University.
• Trustee of the Friends of Griffith University Foundation (USA).
• Member of the Advisory Board of the Asia Pacific Space Centre.

[2][3]

Links

For Wikipedia site see http://en.wikipedia.org/wiki/Rob_Borbidge